Singapore Chartbook: The bumpy path from pandemic to endemic
- Singapore’s encouraging inoculation effort has paved the way for the reopening of the economy
- Both key manufacturing and services sectors are moderating in growth
- We maintain our below-consensus growth forecast of 6.3% in 2021 and 3.2% in 2022
- Inflation is expected to average 1.7% in 2021 while core inflation will likely remain elevated
- The MAS is expected to normalize monetary policy in the forthcoming October meeting
Please download the PDF for the entire chartbook
Singapore has achieved one of the highest inoculation rates in the world. This has prompted the government to proceed with the reopening of the economy. While the process will be carried out in a calibrated manner, it does entail certain degree of risk. As such, we continue to maintain our below-consensus GDP growth forecast of 6.3% in 2021 and 3.2% in 2022. The transition from pandemic to COVID being endemic is expected to be tepid and uneven.
To read the full report, click here to Download the PDF.To unsubscribe, please clickhere.
The information set out in this website ("Information") is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation. This Information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation. This Information is published for general circulation only and does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person. Visitors accessing this website should always seek advice from an independent financial adviser regarding the suitability of the Information referred to herein (taking into account the specific investment objectives, financial situation and/or particular needs of each person in receipt of the Information) before making any investment and/or any purchase in reliance of the Information. Please refer to the actual research publications for important disclaimers and disclosures, where applicable.